Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2024-03.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 88 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 89
1Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
2Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University College of Medicine, Seoul, Korea.
Copyright © 2020 Korean Endocrine Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
AUTHOR CONTRIBUTIONS:
Values are expressed as mean±standard deviation, number (%), or median (interquartile range).
TCPA, The Cancer Proteome Atlas; ENSAT, European Network for the Study of Adrenal Tumors; HPF, high power field; TfR1, transferrin receptor.
aP value for a comparison between patients with metastasis and without metastasis; bThe denominator was patients with complete resection; cThe available number was 32 because of missing values; dThe available number was 33 because of missing values; eThe available number was 43 because of missing values; fThe Mann-Whitney test was used, because the Weiss score and mitotic count did not follow normal distributions.
HR, hazard ratio; CI, confidence interval; ENSAT, European Network for the Study of Adrenal Tumors; TfR1, transferrin receptor.
aMultivariate analyses are adjusted by age and staging; bThe categorization of I+II vs. III+IV was applied using the ENSAT system; cThe reference group is other subjects, such as those except patients with both high cyclin B1 and high TfR1.
HR, hazard ratio; CI, confidence interval; ENSAT, European Network for the Study of Adrenal Tumors; TfR1, transferrin receptor.
aMultivariate analyses were adjusted by age and staging; bThe categorization of I+II vs. III+IV was applied using ENSAT system; cThe reference group is other subjects, such as those except patients with both high cyclin B1 and high TfR1.